Skip to content

Effects of Wearable Devices Initiates Behavioral Change Intervention on Body Composition, Physical Activity, Sleep Quality and Stress of Nurses in Hospital Working Place

Effects of Wearable Devices Initiates Behavioral Change Intervention on Body Composition, Physical Activity, Sleep Quality and Stress of Nurses in Hospital Working Place: A Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06814886
Enrollment
120
Registered
2025-02-07
Start date
2025-05-01
Completion date
2027-03-01
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult, Nurse

Keywords

wearable device, behavioral change intervention, nurse, working place

Brief summary

Background: Physically inactive and poor sleep quality are at increased risk for non-communicable diseases. Nurses were the most vulnerable inactive healthcare personnel who may not meet global physical activity recommendations because of complicated rotation shifts and heavy working loading. Wearable devices initiate behavior intervention combined with smartphone applications could offer new opportunities for social connection by a convenient way for nurses to improve physical activity and sleep quality. Objectives: To evaluate the effects of wearable devices initiate behavioral intervention on body composition, physical activity, sleep quality and stress of nurses in hospital working place. Method: This is a randomized controlled trial that will recruit 120 nurses and randomly assign them into two groups from a hospital working place. The nurses in the intervention group will receive 12-week wearable devices to initiate behavioral intervention. The nurses in the comparison group will only receive 12-week wearable devices monitoring. Data will be collected at baseline and 12-week and 24-week follow-up. The body composition will be measured by bioelectrical impedance analysis (BIA). The physical activity and sleep quality will be monitored by the Fitbit wearable device and application. The mediator parameter of the stress will be measured by salivary amylase activity (SAA). We will control the internal validity to assure the quality of training, treatment fidelity, identify barriers and facilitators of implementation, and assess participants' satisfaction. General estimating equations (GEE) will be applied to examine the effects of time and group interaction.

Interventions

BEHAVIORALwearable devices to initiate behavioral intervention

12 week wearable devices to initiate behavioral intervention including line APP recruited participants and give some behavior change advises, also give a APP-based motivational interviewing 15 minutes per week.

BEHAVIORAL12 week wearable devices monitor

12 week wearable devices monitor physical activity and sleep quality only

Sponsors

Tri-Service General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Individuals who give informed consent for this study and are 20 years old or older. * Those who own a smartphone and are willing to join the study's LINE group. * Individuals whose mobile application (APP) can synchronize with the Fitbit Charge 6 wearable device. * Nurses who hold a nursing license and are working in a clinical setting.

Exclusion criteria

* Individuals unable to provide informed consent for this study and are younger than 20 years old. * Those who do not own a smartphone. * Individuals who do not have a nursing license or are not employed in a clinical setting as a nurse. * Participants who are already involved in other health promotion or exercise training studies. * Nurses who are currently pregnant.

Design outcomes

Primary

MeasureTime frameDescription
Physical activity (subjective)From enrollment to the end of treatment at 12 weeks, and 24 weeks follow upMeasurement Tool: International Physical Activity Questionnaire short form - Taiwan version
Physical activity (objective)From enrollment to the end of treatment at 12 weeks, and 24 weeks follow upMeasurement Tool: Wearing Fitbit Charge 6 HR to collect physical activity and sleep quality related data.

Secondary

MeasureTime frameDescription
Sleep quality (objective)From enrollment to the end of treatment at 12 weeks, and 24 weeks follow upMeasurement Tool: Wearing Fitbit Charge 6 HR to collect physical activity and sleep quality related data.
sleep quality (subjective)From enrollment to the end of treatment at 12 weeks, and 24 weeks follow upMeasurement Tool:Chinese version of the Pittsburgh Sleep Quality Index (CPSQI)
Body compositionFrom enrollment to the end of treatment at 12 weeks, and 24 weeks follow upMeasurement Tool: Inbody 270 Body Composition Analyzer
StressFrom enrollment to the end of treatment at 12 weeks, and 24 weeks follow upMeasurement Tool: Nipro Salivary Amylase Activity Monitor and enzyme-linked immunosorbent assay (ELISA) will be utilized to quantify the levels of irisin, IL-6, and BDNF in serum samples, allowing for the assessment of immune stress values.

Countries

Taiwan

Contacts

Primary ContactYIPANG LO, PhD candidate
winfly1017@hotmail.com886-988-082940

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026